Viz Stock

Viz is a medical imaging company that helps optimize emergency treatment using deep learning technology.

Sign up today and learn more about Viz Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Viz Stock

Viz helps physicians to identify anomalies in brain scans through machine learning. The company leverages advanced deep learning to communicate time-sensitive information about stroke patients straight to a specialist who can intervene and treat. It uses deep learning algorithms to identify a suspected large vessel occlusion, a particularly disabling type of stroke, in a CT scan and alerts the stroke team specialist within minutes. Viz has developed deep learning algorithms to analyze brain scans for large vessel occlusions (LVOs), a disabling type of stroke. The company also allows the stroke center’s clinicians to rapidly share images back and forth. Viz's mission is to fundamentally improve how healthcare is delivered in the world, through intelligent software that promises to reduce time to treatment and improve access to care. Viz was founded in 2016 and is based in San Francisco, California.


Funding History

September 2016$50K
October 2016$2.0M
May 2017$7.5M
July 2018$21.0M
October 2019$50.0M
March 2021$71.0M
April 2022$100M


​CEO, Co-Founder

Chris Mansi

Cofounder & CTO

David Golan


Manoj Ramachandran

Chief Operating Officer

Julie Skaff

Vice President of Sales

Steve Fried


Kurt Blasena

DevOps & Network Engineer

Brian Davis


Conrad Yiu

General Manager & CPO

Gad Sakin

General Counsel and Vice President of Commercial Operations

David Kizner

Board Of Director

Mamoon Hamid

VP of Product

Nir Sheep

VP of Product Management

Maya Mandel

Chief Revenue Officer

Kurt Blasena

VP of Finance

Lisa Garland

Board Member

Neil Shah

Vice President of Marketing

Kavi Vyas


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: